Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2021 | 3 |
2022 | 2 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Brahma-Related Gene-1 (BRG1) promotes the malignant phenotype of glioblastoma cells.
J Cell Mol Med. 2021 Mar;25(6):2956-2966. doi: 10.1111/jcmm.16330. Epub 2021 Feb 2.
J Cell Mol Med. 2021.
PMID: 33528916
Free PMC article.
SS-4 is a highly selective small molecule inhibitor of STAT3 tyrosine phosphorylation that potently inhibits GBM tumorigenesis in vitro and in vivo.
Wang Y, Yang C, Sims MM, Sacher JR, Raje M, Deokar H, Yue P, Turkson J, Buolamwini JK, Pfeffer LM.
Wang Y, et al. Among authors: sims mm.
Cancer Lett. 2022 May 1;533:215614. doi: 10.1016/j.canlet.2022.215614. Epub 2022 Mar 1.
Cancer Lett. 2022.
PMID: 35245627
Item in Clipboard
Novel structural-related analogs of PFI-3 (SRAPs) that target the BRG1 catalytic subunit of the SWI/SNF complex increase the activity of temozolomide in glioblastoma cells.
He Y, Yang C, Wang Y, Sacher JR, Sims MM, Pfeffer LM, Miller DD.
He Y, et al. Among authors: sims mm.
Bioorg Med Chem. 2022 Jan 1;53:116533. doi: 10.1016/j.bmc.2021.116533. Epub 2021 Nov 27.
Bioorg Med Chem. 2022.
PMID: 34863065
Item in Clipboard
APELA Expression in Glioma, and Its Association with Patient Survival and Tumor Grade.
Ganguly D, Cai C, Sims MM, Yang CH, Thomas M, Cheng J, Saad AG, Pfeffer LM.
Ganguly D, et al. Among authors: sims mm.
Pharmaceuticals (Basel). 2019 Mar 26;12(1):45. doi: 10.3390/ph12010045.
Pharmaceuticals (Basel). 2019.
PMID: 30917521
Free PMC article.
Item in Clipboard
Targeting the Bromodomain of BRG-1/BRM Subunit of the SWI/SNF Complex Increases the Anticancer Activity of Temozolomide in Glioblastoma.
Yang C, Wang Y, Sims MM, He Y, Miller DD, Pfeffer LM.
Yang C, et al. Among authors: sims mm.
Pharmaceuticals (Basel). 2021 Sep 6;14(9):904. doi: 10.3390/ph14090904.
Pharmaceuticals (Basel). 2021.
PMID: 34577604
Free PMC article.
Item in Clipboard
Cite
Cite